A therapeutical insight into the correlation between circRNAs and signaling pathways involved in cancer pathogenesis

Raed Obaid Saleh1, Sulieman Ibraheem Shelash Al-Hawary2, Saade Abdalkareem Jasim3

  • 1Department of Medical Laboratory Techniques, Al-Maarif University College, Al-Anbar, Iraq.

Insights

Circular RNAs (circRNAs) have vital roles in cell functions and disease. This review explores their involvement in cancer, highlighting their potential as diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are non-coding RNA molecules formed from back-splicing of pre-messenger RNA.
  • CircRNAs perform critical biological functions, including acting as miRNA sponges, modulating protein activity, and serving as translation templates.
  • Dysregulated circRNA expression is linked to various diseases, particularly cancer, due to the disruption of molecular pathways maintaining homeostasis.

Purpose of the Study:

  • To review the biological and carcinogenic effects of circRNAs in cancer.
  • To highlight the involvement of circRNAs in signal transduction pathways.
  • To explore the potential of circRNAs as novel biomarkers for early cancer detection and prognosis.

Main Methods:

  • Literature review of studies on circRNA biogenesis, function, and role in cancer.
  • Analysis of circRNA involvement in key cancer-related molecular pathways.
  • Evaluation of current evidence for circRNAs as cancer biomarkers.

Main Results:

  • CircRNAs exhibit diverse functions, impacting gene regulation and protein interactions.
  • Aberrant circRNA expression is a hallmark of many cancers, affecting cellular processes.
  • CircRNAs play roles in various cancer-related signal transduction pathways.

Conclusions:

  • CircRNAs are critical players in cancer development and progression.
  • CircRNAs hold significant promise as biomarkers for early cancer diagnosis and prognosis.
  • Targeting circRNAs presents a potential therapeutic strategy for cancer treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K